T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia

Bone Marrow Transplantation

Volumn 21, Issue 5, 1998, Pages 431-440

  Mavroudis, D A ^a   Read, E J ^b   Molldrem, J ^a   Raptis, A ^a   Plante, M ^a   Carter, C S ^b   Phang, S ^a   Dunbar, C E ^a   Barrett, A J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Allogeneic BMT; G CSF; Graft failure; Pancytopenia; T cell depletion

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEVER; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEADACHE; HEMATOPOIETIC STEM CELL; HLA MATCHING; HUMAN; HUMAN CELL; LEUKEMIA; LEUKOCYTE COUNT; LYMPHOMA; MALE; MONOCYTE; MORTALITY; NEUTROPHIL; PANCYTOPENIA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; THROMBOCYTOPENIA;

EID: 0031932984     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701120     Document Type: Article

References (27)

1. Bensinger W, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88: 2794-2800.
2. Miflin G, Russell N, Hutchinson R et al. Allogeneic peripheral blood stem cell transplantation for haematological malignancies - an analysis of kinetics of engraftment and GVHD risk. Bone Marrow Transplant 1997; 19: 9-13.
3. Russell J, Brown C, Bowen T et al. Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplant 1996; 17: 703-708.
4. Ottinger H, Beelen D, Scheulen B et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88: 2775-2779.
5. Majolino I, Saglio G, Seime R et al. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplant 1996; 17: 555-560.
6. + blood cells. Blood 1996; 87: 4903-4909.
7. Janssen W, Perkins J, Hiemenz J et al. Granulocyte recovery is not different following auto-transplant with G-CSF-primed bone marrow or G-CSF mobilized peripheral blood 'stem cells'. Blood 1994; 84 (Suppl. 1): 97a.
8. Hansen P, Knudsen H, Gaarsdal E et al. Short-term in vivo priming of bone marrow haematopoiesis with rhG-CSF, rhGM-CSF or rhIL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability. Blood 1995; 86 (Suppl. 1): 583a.
9. Meisenberg B, Frakes L, Brehm T et al. Use of G-CSF given to allogeneic donors to improve CD34 yields in bone marrow collections and hasten engraftment. Blood 1996; 88 (Suppl. 1): 403a.
10. Isola L, Scigliano E, Skerrett D et al. Allogeneic bone marrow transplantation using bone marrow from G-CSF stimulated donors. Blood 1996; 88 (Suppl. 1): 403a.
11. + cell dose predicts survival, post-transplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 1996; 88: 3223-3229.
12. Johnsen HE, Jensen L, Gaarsdal E et al. Priming with recombinant human hematopoietic cytokines before bone marrow havest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures. Exp Hematol 1994; 22: 80-86.
13. + cells. Prog Clin Biol Res 1994; 389: 363-369.
14. + hematopoietic cells using an immunoaffinity column results in T cell depletion equivalent to elutriation. Exp Hematol 1995; 23: 320-322.
15. + cells in bone marrow by flow cytometry. J Hematother 1993; 2: 305-315.
16. Prentice H, Gluckman E, Powles R et al. for the European Acyclovir for CMV Prophylaxis Study Group. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. Lancet 1994; 343: 749-753.
17. Couriel D, Canosa J, Engler H et al. Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies. Bone Marrow Transplant 1996; 18: 347-353.
18. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
19. Peto R, Peto J. Asymptomatically efficient rank invariant procedures. JR Stat Soc 1972; 135: 185-191.
20. Barrett J, Mavroudis D, Molldrem J et al. Optimizing the dose and timing of lymphocyte add-back in T cell-depleted BMT between HLA-identical siblings. Blood 1996; 88 (Suppl. 1). 460a.
21. Bodine D, Seidel N, Orlic D. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 1996; 88: 89-97.
22. Dunbar C, Seidel N, Doren S et al. Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 1996; 93: 11871-11876.
23. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996; 273: 242-245.
24. Goodell M, Brose K, Paradis G et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996; 183: 1797-1866.
25. Johnson R, Rosenzweig M, Goodell M et al. Identification of a candidate hematopoietic stem cell population that lacks CD34 in rhesus macaques. Blood 1996; 88: 629a.
26. Atkinson K, Fay K, Nivison-Smith I, Downs K. Lenograstim administration to HLA-identical donor-recipient pairs to accelerate marrow recovery post-transplant. Bone Marrow Transplant 1997; 19: 15-21.
27. Reisner Y, Martelli M. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol Today 1995; 16: 437-440.